 | • レポートコード：GIR-105X01327 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、非定型抗精神病薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。非定型抗精神病薬の種類別市場規模（リスペリドン、オランザピン、クエチアピン、ジプラシドン、その他）、用途別市場規模（双極I型障害、統合失調症、統合失調感情障害、大うつ病性障害（MDD））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・非定型抗精神病薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis AG、Cardinal Health、Johnson and Johnson、Allergan、Sanis Health、Pfizer、GlaxoSmithKline、Bristol-Myers Squibb Company、Sun Pharmaceutical Industries、Eil Lilly and Company、AstraZeneca、Sumitomo Dainippon Pharma、Qilu Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リスペリドン、オランザピン、クエチアピン、ジプラシドン、その他 ・用途別分析2016年-2026年：双極I型障害、統合失調症、統合失調感情障害、大うつ病性障害（MDD） ・非定型抗精神病薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・非定型抗精神病薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・非定型抗精神病薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・非定型抗精神病薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・非定型抗精神病薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Atypical Antipsychotic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Atypical Antipsychotic Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Atypical Antipsychotic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Atypical Antipsychotic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Risperidone
Olanzapine
Quetiapine
Ziprasidone
Others
Market segment by Application can be divided into
Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Major Depressive Disorder (MDD)
The key market players for global Atypical Antipsychotic Drugs market are listed below:
Novartis AG
Cardinal Health
Johnson and Johnson
Allergan
Sanis Health
Pfizer
GlaxoSmithKline
Bristol-Myers Squibb Company
Sun Pharmaceutical Industries
Eil Lilly and Company
AstraZeneca
Sumitomo Dainippon Pharma
Qilu Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Atypical Antipsychotic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Atypical Antipsychotic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Risperidone
1.2.3 Olanzapine
1.2.4 Quetiapine
1.2.5 Ziprasidone
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Atypical Antipsychotic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Bipolar I Disorder
1.3.3 Schizophrenia
1.3.4 Schizoaffective Disorder
1.3.5 Major Depressive Disorder (MDD)
1.4 Global Atypical Antipsychotic Drugs Market Size & Forecast
1.4.1 Global Atypical Antipsychotic Drugs Sales in Value (2016-2026))
1.4.2 Global Atypical Antipsychotic Drugs Sales in Volume (2016-2026)
1.4.3 Global Atypical Antipsychotic Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Atypical Antipsychotic Drugs Production Capacity Analysis
1.5.1 Global Atypical Antipsychotic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Atypical Antipsychotic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Atypical Antipsychotic Drugs Market Drivers
1.6.2 Atypical Antipsychotic Drugs Market Restraints
1.6.3 Atypical Antipsychotic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Atypical Antipsychotic Drugs Product and Services
2.1.4 Novartis AG Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Cardinal Health
2.2.1 Cardinal Health Details
2.2.2 Cardinal Health Major Business
2.2.3 Cardinal Health Atypical Antipsychotic Drugs Product and Services
2.2.4 Cardinal Health Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Atypical Antipsychotic Drugs Product and Services
2.3.4 Johnson and Johnson Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Atypical Antipsychotic Drugs Product and Services
2.4.4 Allergan Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanis Health
2.5.1 Sanis Health Details
2.5.2 Sanis Health Major Business
2.5.3 Sanis Health Atypical Antipsychotic Drugs Product and Services
2.5.4 Sanis Health Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Atypical Antipsychotic Drugs Product and Services
2.6.4 Pfizer Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Atypical Antipsychotic Drugs Product and Services
2.7.4 GlaxoSmithKline Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Bristol-Myers Squibb Company
2.8.1 Bristol-Myers Squibb Company Details
2.8.2 Bristol-Myers Squibb Company Major Business
2.8.3 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product and Services
2.8.4 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sun Pharmaceutical Industries
2.9.1 Sun Pharmaceutical Industries Details
2.9.2 Sun Pharmaceutical Industries Major Business
2.9.3 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product and Services
2.9.4 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Eil Lilly and Company
2.10.1 Eil Lilly and Company Details
2.10.2 Eil Lilly and Company Major Business
2.10.3 Eil Lilly and Company Atypical Antipsychotic Drugs Product and Services
2.10.4 Eil Lilly and Company Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Atypical Antipsychotic Drugs Product and Services
2.11.4 AstraZeneca Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Sumitomo Dainippon Pharma
2.12.1 Sumitomo Dainippon Pharma Details
2.12.2 Sumitomo Dainippon Pharma Major Business
2.12.3 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product and Services
2.12.4 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Qilu Pharmaceutical
2.13.1 Qilu Pharmaceutical Details
2.13.2 Qilu Pharmaceutical Major Business
2.13.3 Qilu Pharmaceutical Atypical Antipsychotic Drugs Product and Services
2.13.4 Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Atypical Antipsychotic Drugs Sales by Manufacturer
3.1 Global Atypical Antipsychotic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Atypical Antipsychotic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Atypical Antipsychotic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Atypical Antipsychotic Drugs Manufacturer Market Share
3.4.2 Top 6 Atypical Antipsychotic Drugs Manufacturer Market Share
3.5 Global Atypical Antipsychotic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Atypical Antipsychotic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Atypical Antipsychotic Drugs Market Size by Region
4.1.1 Global Atypical Antipsychotic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Atypical Antipsychotic Drugs Revenue by Region (2016-2026)
4.2 North America Atypical Antipsychotic Drugs Revenue (2016-2026)
4.3 Europe Atypical Antipsychotic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Atypical Antipsychotic Drugs Revenue (2016-2026)
4.5 South America Atypical Antipsychotic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Atypical Antipsychotic Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Atypical Antipsychotic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Atypical Antipsychotic Drugs Revenue by Type (2016-2026)
5.3 Global Atypical Antipsychotic Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Atypical Antipsychotic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Atypical Antipsychotic Drugs Revenue by Application (2016-2026)
6.3 Global Atypical Antipsychotic Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Atypical Antipsychotic Drugs Sales by Type (2016-2026)
7.2 North America Atypical Antipsychotic Drugs Sales by Application (2016-2026)
7.3 North America Atypical Antipsychotic Drugs Market Size by Country
7.3.1 North America Atypical Antipsychotic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Atypical Antipsychotic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Atypical Antipsychotic Drugs Sales by Type (2016-2026)
8.2 Europe Atypical Antipsychotic Drugs Sales by Application (2016-2026)
8.3 Europe Atypical Antipsychotic Drugs Market Size by Country
8.3.1 Europe Atypical Antipsychotic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Atypical Antipsychotic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Atypical Antipsychotic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Atypical Antipsychotic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Atypical Antipsychotic Drugs Market Size by Region
9.3.1 Asia-Pacific Atypical Antipsychotic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Atypical Antipsychotic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Atypical Antipsychotic Drugs Sales by Type (2016-2026)
10.2 South America Atypical Antipsychotic Drugs Sales by Application (2016-2026)
10.3 South America Atypical Antipsychotic Drugs Market Size by Country
10.3.1 South America Atypical Antipsychotic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Atypical Antipsychotic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Atypical Antipsychotic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Atypical Antipsychotic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Atypical Antipsychotic Drugs Market Size by Country
11.3.1 Middle East & Africa Atypical Antipsychotic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Atypical Antipsychotic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Atypical Antipsychotic Drugs Typical Distributors
12.3 Atypical Antipsychotic Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Atypical Antipsychotic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Atypical Antipsychotic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Atypical Antipsychotic Drugs Product and Services
Table 6. Novartis AG Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 8. Cardinal Health Major Business
Table 9. Cardinal Health Atypical Antipsychotic Drugs Product and Services
Table 10. Cardinal Health Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson and Johnson Major Business
Table 13. Johnson and Johnson Atypical Antipsychotic Drugs Product and Services
Table 14. Johnson and Johnson Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Allergan Basic Information, Manufacturing Base and Competitors
Table 16. Allergan Major Business
Table 17. Allergan Atypical Antipsychotic Drugs Product and Services
Table 18. Allergan Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanis Health Basic Information, Manufacturing Base and Competitors
Table 20. Sanis Health Major Business
Table 21. Sanis Health Atypical Antipsychotic Drugs Product and Services
Table 22. Sanis Health Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Atypical Antipsychotic Drugs Product and Services
Table 26. Pfizer Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline Major Business
Table 29. GlaxoSmithKline Atypical Antipsychotic Drugs Product and Services
Table 30. GlaxoSmithKline Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Company Major Business
Table 33. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product and Services
Table 34. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 36. Sun Pharmaceutical Industries Major Business
Table 37. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product and Services
Table 38. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Eil Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 40. Eil Lilly and Company Major Business
Table 41. Eil Lilly and Company Atypical Antipsychotic Drugs Product and Services
Table 42. Eil Lilly and Company Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Atypical Antipsychotic Drugs Product and Services
Table 46. AstraZeneca Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Sumitomo Dainippon Pharma Major Business
Table 49. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product and Services
Table 50. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Qilu Pharmaceutical Major Business
Table 53. Qilu Pharmaceutical Atypical Antipsychotic Drugs Product and Services
Table 54. Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Atypical Antipsychotic Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Atypical Antipsychotic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Atypical Antipsychotic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Atypical Antipsychotic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Atypical Antipsychotic Drugs Production Site of Key Manufacturer
Table 60. Global Atypical Antipsychotic Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Global Atypical Antipsychotic Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Global Atypical Antipsychotic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Atypical Antipsychotic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Atypical Antipsychotic Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Global Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Global Atypical Antipsychotic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Atypical Antipsychotic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Atypical Antipsychotic Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 69. Global Atypical Antipsychotic Drugs Price by Type (2021-2026) & (USD/Unit)
Table 70. Global Atypical Antipsychotic Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. Global Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Global Atypical Antipsychotic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Atypical Antipsychotic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Atypical Antipsychotic Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 75. Global Atypical Antipsychotic Drugs Price by Application (2021-2026) & (USD/Unit)
Table 76. North America Atypical Antipsychotic Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. North America Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (K Units)
Table 78. North America Atypical Antipsychotic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Atypical Antipsychotic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Atypical Antipsychotic Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. North America Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (K Units)
Table 82. North America Atypical Antipsychotic Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. North America Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Europe Atypical Antipsychotic Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (K Units)
Table 86. Europe Atypical Antipsychotic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Atypical Antipsychotic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Atypical Antipsychotic Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (K Units)
Table 90. Europe Atypical Antipsychotic Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Atypical Antipsychotic Drugs Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Atypical Antipsychotic Drugs Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Atypical Antipsychotic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Atypical Antipsychotic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Atypical Antipsychotic Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Atypical Antipsychotic Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (K Units)
Table 100. South America Atypical Antipsychotic Drugs Sales by Country (2016-2021e) & (K Units)
Table 101. South America Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (K Units)
Table 102. South America Atypical Antipsychotic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Atypical Antipsychotic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Atypical Antipsychotic Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. South America Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (K Units)
Table 106. South America Atypical Antipsychotic Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. South America Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Atypical Antipsychotic Drugs Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Atypical Antipsychotic Drugs Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Atypical Antipsychotic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Atypical Antipsychotic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Atypical Antipsychotic Drugs Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Atypical Antipsychotic Drugs Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Atypical Antipsychotic Drugs Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Atypical Antipsychotic Drugs Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Atypical Antipsychotic Drugs Typical Distributors
Table 119. Atypical Antipsychotic Drugs Typical Customers
List of Figures
Figure 1. Atypical Antipsychotic Drugs Picture
Figure 2. Global Atypical Antipsychotic Drugs Sales Market Share by Type in 2020
Figure 3. Risperidone
Figure 4. Olanzapine
Figure 5. Quetiapine
Figure 6. Ziprasidone
Figure 7. Others
Figure 8. Global Atypical Antipsychotic Drugs Sales Market Share by Application in 2020
Figure 9. Bipolar I Disorder
Figure 10. Schizophrenia
Figure 11. Schizoaffective Disorder
Figure 12. Major Depressive Disorder (MDD)
Figure 13. Global Atypical Antipsychotic Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Atypical Antipsychotic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Atypical Antipsychotic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Atypical Antipsychotic Drugs Sales (2016-2026) & (K Units)
Figure 35. Global Atypical Antipsychotic Drugs Production Capacity (2016-2026) & (K Units)
Figure 36. Global Atypical Antipsychotic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Atypical Antipsychotic Drugs Market Drivers
Figure 38. Atypical Antipsychotic Drugs Market Restraints
Figure 39. Atypical Antipsychotic Drugs Market Trends
Figure 40. Global Atypical Antipsychotic Drugs Sales Market Share by Manufacturer in 2020
Figure 41. Global Atypical Antipsychotic Drugs Revenue Market Share by Manufacturer in 2020
Figure 42. Atypical Antipsychotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Atypical Antipsychotic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Atypical Antipsychotic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2016-2026)
Figure 46. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2016-2026)
Figure 47. North America Atypical Antipsychotic Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Europe Atypical Antipsychotic Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Atypical Antipsychotic Drugs Revenue (2016-2026) & (USD Million)
Figure 50. South America Atypical Antipsychotic Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Atypical Antipsychotic Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Global Atypical Antipsychotic Drugs Sales Market Share by Type (2016-2026)
Figure 53. Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2016-2026)
Figure 54. Global Atypical Antipsychotic Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 55. Global Atypical Antipsychotic Drugs Sales Market Share by Application (2016-2026)
Figure 56. Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2016-2026)
Figure 57. Global Atypical Antipsychotic Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 58. North America Atypical Antipsychotic Drugs Sales Market Share by Country (2016-2026)
Figure 59. North America Atypical Antipsychotic Drugs Revenue Market Share by Country (2016-2026)
Figure 60. North America Atypical Antipsychotic Drugs Sales Market Share by Type (2016-2026)
Figure 61. North America Atypical Antipsychotic Drugs Sales Market Share by Application (2016-2026)
Figure 62. Europe Atypical Antipsychotic Drugs Sales Market Share by Country (2016-2026)
Figure 63. Europe Atypical Antipsychotic Drugs Revenue Market Share by Country (2016-2026)
Figure 64. Europe Atypical Antipsychotic Drugs Sales Market Share by Type (2016-2026)
Figure 65. Europe Atypical Antipsychotic Drugs Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Atypical Antipsychotic Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Atypical Antipsychotic Drugs Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Atypical Antipsychotic Drugs Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Atypical Antipsychotic Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Atypical Antipsychotic Drugs Sales Market Share by Country (2016-2026)
Figure 71. South America Atypical Antipsychotic Drugs Revenue Market Share by Country (2016-2026)
Figure 72. South America Atypical Antipsychotic Drugs Sales Market Share by Type (2016-2026)
Figure 73. South America Atypical Antipsychotic Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Atypical Antipsychotic Drugs Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Atypical Antipsychotic Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Atypical Antipsychotic Drugs Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Atypical Antipsychotic Drugs Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
抗精神病薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Scope of the Report: This report focuses on the An…- 世界の双極性障害治療薬市場 2021：企業別、地域別、種類・用途別 The Bipolar Disorder Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 双極性障害の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…
- 統合失調症治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition. Scope of the Report: This report studies the Schizophrenia Therapeutics market status and outlook of Globa…
- 睡眠障害治療薬の世界市場2018-2025 Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.Factors such as increasing incidences of depression and other medical disorders, late night working schedule, busy lifestyle, lack of qua…